/ Eli Lilly


LLY Stock Rebounds Amid AI-Driven ALS Research Breakthroughs
/ Market Analysis

LLY Stock Rebounds Amid AI-Driven ALS Research Breakthroughs

Verge Genomics and Eli Lilly have made significant progress in their collaboration to develop ALS treatments, identifying two promising drug targets using AI ...

November 20, 2024
The Weight Loss Market Can Surge to $400 B by 2032, and these Stocks Will Rule it

The Weight Loss Market Can Surge to $400 B by 2032, and these Stocks Will Rule it

Despite Novo Nordisk's momentum, Eli Lilly seems a better long-term bet. Pfizer could surprise everyone from an undervalued position.

July 12, 2024
LLY vs NVO: Which One is Likely to Become a $1T Company First

LLY vs NVO: Which One is Likely to Become a $1T Company First

Tackling growing waistlines is expected to yield much shareholder value.

February 08, 2024
Pfizer’s Stock is Down 44% YTD as Woes Continue

Pfizer’s Stock is Down 44% YTD as Woes Continue

Pfizer's shares plunged on Friday after the drugmaker halted the trial of its twice-daily obesity drug.

December 01, 2023
LLY and NOVO Report Strong Earnings But Are Vulnerable to Q4 Headwinds

LLY and NOVO Report Strong Earnings But Are Vulnerable to Q4 Headwinds

Eli Lilly and Novo Nordisk continue to capitalize on unprecedented interest for weight-loss drugs, with both companies posting strong Q3 results on Thursday.

November 02, 2023

More from The Tokenist / Eli Lilly

100% FREE TRIAL: Learn how to day trade (the right way) with the #1 voted live trading room!

X